Health NZ | Te Whatu Ora FHIR Screening Implementation Guide
0.9.2 - draft
Health NZ | Te Whatu Ora FHIR Screening Implementation Guide - Local Development build (v0.9.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
As at 06-03-2024
| Full Name | Madeleine Meringue | Date of Birth | 24-11-2008 |
| Ethnicity | New Zealand European | NHI Number | ZCU7824 |
| Gender | Female | Sex assigned at birth |
Female |
| Address | 373 Jackson Street, Petone, Lower Hutt 5012, New Zealand |
| Pathway Status | 5 Year Recall | Immune Deficient | No |
| Next Expected Event | Eligibility Notification | Total Hysterectomy | No |
| Next Event Due Date | 24-11-2033 | Cervical Cancer | No |
| Send programme correspondence |
Yes | ||
| Unenrolled reason | Patient overseas for 2 years |
| Specimen Type | LBC - Liquid based cytology |
| Specimen Id | ZKJ2269 |
| Site Code | R- Cervical |
| Specimen Taker | Mickey Dee |
| Requested By Facility | Dr Jane John Surgery |
| Received By Facility | Allana Family Planning Clinic |
| Adequacy | S1 - The specimen is satisfactory for evaluation |
| Interpretation | 02 - There are fungal organisms morphologically consistent with Candida species |
| General Category | G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY |
| Recommendation | H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient |
| Grade | N- Negative |
| Specimen Type | LBC - Liquid based cytology |
| Specimen Id | ZKJ2269 |
| Site Code | R- Cervical |
| Specimen Taker | Mickey Dee |
| Requested By Facility | Dr Jane John Surgery |
| Received By Facility | Allana Family Planning Clinic |
| Adequacy | S1 - The specimen is satisfactory for evaluation |
| Interpretation | 02 - There are fungal organisms morphologically consistent with Candida species |
| General Category | G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY |
| Recommendation | H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient |
| Grade | N- Negative |